CYP3A4 and infection: • Increase concentration with strong CYP3A4 inhibitors; monitoring vs dose reduction• May decrease concentration of CYP3A4 substrates• Increased infection risk with other drugs that suppress the immune system• Separate by 2 hours from magnesium antacids when oral route used• Monitor potassium with other drugs that decrease potassium (eg, diuretics)